Skip to Main Content

INFORMATION FOR

Aldo Peixoto, MD

Professor of Medicine (Nephrology); Vice Chair for Quality & Safety, Department of Internal Medicine; Clinical Chief, Section of Nephrology

Contact Information

Aldo Peixoto, MD

Office Location

Mailing Address

  • Nephrology

    PO Box 208029

    New Haven, CT 06520-8029

    United States

Research Summary

My primary interest has been in the interplay between hypertension, kidney disease and vascular disease. Current interests include:

- Profile and outcomes of acute severe hypertension in hospitalized patients (Lama Ghazi MD PhD, Aldo Peixoto MD and Perry Wilson MD).

- Use of systemic hemodynamics to phenotype hypertension as a tool to redefine mechanisms of hypertension (cross sectional study, PI Marcelo Orias MD PhD).

- Study of arterial mechanics in elderly patients with hypertension (cohort study, PI Sebastiao Ferreira MD PhD).

- Clinical trials (Site PI: Aldo Peixoto): 1) droxidopa in neurogenic orthostatic hypotension (RESTORE).

(Updated January 2022)

Coauthors

Research Interests

Antihypertensive Agents; Hemodynamics; Hypertension; Hypotension, Orthostatic; Reproducibility of Results; Vascular Stiffness; Hemodynamic Monitoring

Research Images

Selected Publications

  • Abstract 57: Risk Factors For Severe Reductions In Blood Pressure After Treatment Of Severe Inpatient HypertensionGhazi L, Li F, Chen E, Simonov M, Yamamoto Y, Biswas A, Hanna J, Shah T, Peixoto A, Wilson F. Abstract 57: Risk Factors For Severe Reductions In Blood Pressure After Treatment Of Severe Inpatient Hypertension Hypertension 2021, 78 DOI: 10.1161/hyp.78.suppl_1.57.
  • Abstract P110: Intravenous Hydralazine Effect On Blood Pressure Following Severe Inpatient Hypertension DevelopmentGhazi L, Li F, Chen E, SIMONOV M, Yamamoto Y, Biswas A, Hanna J, Shah T, Peixoto A, Wilson F. Abstract P110: Intravenous Hydralazine Effect On Blood Pressure Following Severe Inpatient Hypertension Development Hypertension 2021, 78 DOI: 10.1161/hyp.78.suppl_1.p110.
  • ASSOCIATION BETWEEN CARDIOVASCULAR RISK ESTIMATION BY THE ASCVD RISK ESTIMATOR AND CAROTID-FEMORAL PULSE WAVE VELOCITY IN OLDER INDIVIDUALSFerreira-Filho S, Souza D, Freitas E, Peixoto A, Araujo L. ASSOCIATION BETWEEN CARDIOVASCULAR RISK ESTIMATION BY THE ASCVD RISK ESTIMATOR AND CAROTID-FEMORAL PULSE WAVE VELOCITY IN OLDER INDIVIDUALS Journal Of Hypertension 2021, 39: e167. DOI: 10.1097/01.hjh.0000746248.89781.62.
  • Chapter 46 Approach to the Patient with Hypertensive NephrosclerosisPeixoto A, Bakris G. Chapter 46 Approach to the Patient with Hypertensive Nephrosclerosis 2020, 737-752. DOI: 10.1016/b978-0-12-815876-0.00046-2.
  • MON-334 TWO FORMS OF RENALASE (BOUND AND FREE) IDENTIFIED IN HUMAN PLASMA BY A NEW ELISARao V, Guo X, Chang J, Peixoto A, Testani J, Desir G. MON-334 TWO FORMS OF RENALASE (BOUND AND FREE) IDENTIFIED IN HUMAN PLASMA BY A NEW ELISA Kidney International Reports 2019, 4: s67. DOI: 10.1016/j.ekir.2019.05.180.
  • SAT-183 % FREE RENALASE IS ASSOCIATED WITH PROGRESSION OF CKD, AND IS AN INDEPENDENT PREDICTOR OF ALL CAUSE MORTALITYDesir G, Chang J, Guo X, Gromisch E, Peixoto A. SAT-183 % FREE RENALASE IS ASSOCIATED WITH PROGRESSION OF CKD, AND IS AN INDEPENDENT PREDICTOR OF ALL CAUSE MORTALITY Kidney International Reports 2019, 4: s84-s85. DOI: 10.1016/j.ekir.2019.05.217.
  • Assessment of Hypertension in Chronic Kidney DiseasePeixoto A. Assessment of Hypertension in Chronic Kidney Disease 2016, 15-33. DOI: 10.1007/978-1-4939-6436-9_2.
  • PS 08-77 AGREEMENT AMONG SEQUENTIAL CAROTID-FEMORAL PULSE WAVE VELOCITY (CF-PWV) MEASUREMENTS IN ELDERLY HYPERTENSIVE PATIENTS(*)Souza D, de Alvarenga Brunelli A, Peres C, Dorneles M, de Assis Nolasco G, Mendonca G, Freitas E, Peixoto A, Ferreira-Filho S. PS 08-77 AGREEMENT AMONG SEQUENTIAL CAROTID-FEMORAL PULSE WAVE VELOCITY (CF-PWV) MEASUREMENTS IN ELDERLY HYPERTENSIVE PATIENTS(*) Journal Of Hypertension 2016, 34: e314. DOI: 10.1097/01.hjh.0000500771.66141.71.
  • Agreement among sequential carotid-femoral pulse wave velocity (cf-PWV) measurements in elderly hypertensive patientsSouza D, Brunelli A, Peres C, Dorneles M, Nolasco G, Mendonça G, Freitas E, Peixoto A, Ferreira-Filho S. Agreement among sequential carotid-femoral pulse wave velocity (cf-PWV) measurements in elderly hypertensive patients International Journal Of Cardiology Cardiovascular Risk And Prevention 2016, 10: e36-e37. DOI: 10.1016/j.jash.2016.03.086.
  • Ambulatory Blood Pressure in Patients with Chronic Kidney DiseaseAsch W, Santos S, Peixoto A. Ambulatory Blood Pressure in Patients with Chronic Kidney Disease 2016, 277-298. DOI: 10.1007/978-3-319-22771-9_14.
  • Managing Blood Pressure in the Elderly: What Is Different?Santos S, Pazhayattil G, Peixoto A. Managing Blood Pressure in the Elderly: What Is Different? 2015, 67-83. DOI: 10.1007/978-1-4939-3320-4_7.
  • Chapter 38 Approach to the Patient with Hypertensive NephrosclerosisPeixoto A, Bakris G. Chapter 38 Approach to the Patient with Hypertensive Nephrosclerosis 2015, 455-469. DOI: 10.1016/b978-0-12-411602-3.00038-x.
  • Response to ‘“Labile hypertension” can be due to autonomic nervous system failure’Peixoto A, Zar T. Response to ‘“Labile hypertension” can be due to autonomic nervous system failure’ Kidney International 2009, 75: 860-861. DOI: 10.1038/ki.2008.670.
  • 174 Vasopressin Response in Intradialytic HypotensionRho M, Perazella M, Peixoto A, Parikh C, Brewster U. 174 Vasopressin Response in Intradialytic Hypotension American Journal Of Kidney Diseases 2007, 49: b68. DOI: 10.1053/j.ajkd.2007.02.181.
  • Ambulatory Blood Pressure in Patients With Chronic Kidney DiseaseSantos S, Peixoto A. Ambulatory Blood Pressure in Patients With Chronic Kidney Disease 2007, 389-410. DOI: 10.1007/978-1-59259-978-3_16.
  • Kidney and Blood Pressure—The Story Unfolds Renalase Is a Novel, Soluble Monoamine Oxidase That Regulates Cardiac Function and Blood Pressure. J Clin InvestJ X, G L, P W, H V, X Y, Y L, Y W, A P, S C, GV D. Kidney and Blood Pressure—The Story Unfolds Renalase Is a Novel, Soluble Monoamine Oxidase That Regulates Cardiac Function and Blood Pressure. J Clin Invest Journal Of The American Society Of Nephrology 2005, 16: 2521-2527. DOI: 10.1681/asn.2005070751.
  • Prediction of interdialytic ambulatory blood pressure in 91 hemodialysis patientsSantos S, Mendes R, Crowley S, Mansoor G, White W, Peixoto A. Prediction of interdialytic ambulatory blood pressure in 91 hemodialysis patients American Journal Of Hypertension 2000, 13: s290-s291. DOI: 10.1016/s0895-7061(00)01059-1.
  • Reproducibility of ambulatory blood pressure in hemodialysis patientsPeixoto A, Santos S, Mendes R, Crowley S, Orias M, Maldonado R, Mansoor G, White W. Reproducibility of ambulatory blood pressure in hemodialysis patients American Journal Of Hypertension 2000, 13: s223. DOI: 10.1016/s0895-7061(00)00757-3.
  • Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patientsPeixoto A, Gray T, Crowley S. Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patients Blood Pressure Monitoring 1999, 4: 217-221. DOI: 10.1097/00126097-199910000-00003.
  • Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patientsPeixoto A, Gray T, Crowley S. Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patients Blood Pressure Monitoring 1999, 4: 217???226. DOI: 10.1097/00126097-199904000-00003.